The U.S. Food and Drug Administration (“FDA”) recently approved use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of the COVID-19 disease in individuals 16 years of age or older. Previously, all COVID-19 vaccinations administered in the United States were approved through Emergency Use Authorization (“EUA”), which enables the FDA to allow for use of…
Impact on Employers of the FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine
POSTED IN: COVID-19, Employment Law, News